Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Non Operating Income: 2011-2025

Historic Non Operating Income for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to $1.8 million.

  • Enanta Pharmaceuticals' Non Operating Income fell 142.22% to -$282,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 53.88%. This contributed to the annual value of $1.8 million for FY2025, which is 53.88% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Non Operating Income of $1.8 million as of FY2025, which was down 53.88% from $3.9 million recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Non Operating Income ranged from a high of $6.2 million in FY2023 and a low of $1.7 million during FY2022.
  • Moreover, its 3-year median value for Non Operating Income was $3.9 million (2024), whereas its average is $4.0 million.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Non Operating Income tumbled by 69.88% in 2021 and then surged by 275.12% in 2023.
  • Over the past 5 years, Enanta Pharmaceuticals' Non Operating Income (Yearly) stood at $2.0 million in 2021, then fell by 16.95% to $1.7 million in 2022, then soared by 275.12% to $6.2 million in 2023, then crashed by 37.17% to $3.9 million in 2024, then crashed by 53.88% to $1.8 million in 2025.